Overview

Efficiency and Tolerance of Rituximab (mabthéra) in Bullous Pemphigoid

Status:
Completed
Trial end date:
2013-12-01
Target enrollment:
Participant gender:
Summary
The aim of the study is to assess that it will be possible to control with a single cycle of rituximab patient with bullous pemphigoid.
Phase:
Phase 3
Details
Lead Sponsor:
University Hospital, Rouen
Treatments:
Rituximab